HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER:

# Drug Count
0 ZOLEDRONIC ACID 3
1 FULVESTRANT 2
2 TIRZEPATIDE 2
3 TRASTUZUMAB 2
4 CAPECITABINE 1
5 CYCLOPHOSPHAMIDE 1
6 CYCLOPHOSPHAMIDE FOR INJECTION 1
7 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1
8 LETROZOLE 1
9 LETROZOLE TABLETS 1
See all common drugs associated with HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER

HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZOLEDRONIC ACID 3 0.0001
1 FULVESTRANT 2 0.0001
2 RIBOCICLIB 1 0.0000
3 TRASTUZUMAB 2 0.0000
4 LETROZOLE TABLETS 1 0.0000
5 LETROZOLE 1 0.0000
6 TIRZEPATIDE 2 0.0000
7 CAPECITABINE 1 0.0000
8 PALBOCICLIB 1 0.0000
9 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
See all drugs enriched for association with HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER

HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Estrogen Receptor Antagonist [EPC] 2 0.0000
2 HER2/neu Receptor Antagonist [EPC] 3 0.0000
3 Aromatase Inhibitor [EPC] 1 0.0000
4 GLP-1 Receptor Agonist [EPC] 2 0.0000
5 Alkylating Drug [EPC] 1 0.0000
6 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
7 Kinase Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with HORMONE RECEPTOR NEGATIVE HER2 POSITIVE BREAST CANCER